FORM 6-K 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 

of the Securities Exchange Act of 1934

 

For the month of June 2015

 

Commission File Number: 001-15152

 

SYNGENTA AG 

(Translation of registrant’s name into English)

 

Schwarzwaldallee 215 

4058 Basel

Switzerland

 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

  Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes   No

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes   No

 

Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

 

Yes   No

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 
 
 

 

    SYNGENTA AG  
       
       
Date: June 23, 2015   By: /s/ Sandra Bürli-Borner  
        Name: Dr. Sandra Bürli-Borner  
        Title: Deputy Head Shareholder Services  
             
             
             
             
             
             
             
      By: /s/ Brigitte Benz  
        Name: Brigitte Benz  
        Title: Head Shareholder Services &
Group Administration
 
             

 
 

 

Re:               SYNGENTA AG

 

Disclosure: “Syngenta Chairman comments on Monsanto’s recent approach”

 

 

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:

 

# # #

 

 

 

  

Syngenta International AG

 

Media Office 

CH-4002 Basel 

Switzerland 

Tel:              +41 61 323 2323 

Fax:             +41 61 323 2424

 

www.syngenta.com

 

Media contacts:

 

Paul Barrett 

Switzerland    +41 61 323 2323

 

Brunswick 

Jon Coles/ Richard Jacques (UK) 

+44 207 404 5959 

Monika Driscoll/Tripp Kyle (US) 

+1 (212) 333 3810 

Analyst/Investor contacts:

 

Jennifer Gough 

Switzerland +41 61 323 5059 

USA           +1 202 737 6521

 

Lars Oestergaard 

Switzerland +41 61 323 6793 

USA           +1 202 737 6520

 

 

 

Basel, Switzerland, June 23, 2015

 

Syngenta Chairman comments on Monsanto’s recent approach

 

The Chairman of Syngenta’s Board of Directors, Michel Demaré, today outlined the company’s position on Monsanto’s recent approach, which was rejected for not being in the best interests of Syngenta, its shareholders and its stakeholders.

 

Mr Demaré’s video interview can be viewed here

 

Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.